Axogen, Inc.

NasdaqCM:AXGN Stock Report

Market Cap: US$567.7m

Axogen Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureless than a year
Board average tenure3.8yrs

Recent management updates

Recent updates

Even With A 28% Surge, Cautious Investors Are Not Rewarding AxoGen, Inc.'s (NASDAQ:AXGN) Performance Completely

Sep 14
Even With A 28% Surge, Cautious Investors Are Not Rewarding AxoGen, Inc.'s (NASDAQ:AXGN) Performance Completely

Would AxoGen (NASDAQ:AXGN) Be Better Off With Less Debt?

Aug 20
Would AxoGen (NASDAQ:AXGN) Be Better Off With Less Debt?

A Piece Of The Puzzle Missing From AxoGen, Inc.'s (NASDAQ:AXGN) 28% Share Price Climb

Jul 29
A Piece Of The Puzzle Missing From AxoGen, Inc.'s (NASDAQ:AXGN) 28% Share Price Climb

Market Might Still Lack Some Conviction On AxoGen, Inc. (NASDAQ:AXGN) Even After 27% Share Price Boost

Jun 12
Market Might Still Lack Some Conviction On AxoGen, Inc. (NASDAQ:AXGN) Even After 27% Share Price Boost

Is AxoGen (NASDAQ:AXGN) Using Too Much Debt?

Apr 16
Is AxoGen (NASDAQ:AXGN) Using Too Much Debt?

Positive Sentiment Still Eludes AxoGen, Inc. (NASDAQ:AXGN) Following 26% Share Price Slump

Mar 28
Positive Sentiment Still Eludes AxoGen, Inc. (NASDAQ:AXGN) Following 26% Share Price Slump

Market Might Still Lack Some Conviction On AxoGen, Inc. (NASDAQ:AXGN) Even After 33% Share Price Boost

Jan 26
Market Might Still Lack Some Conviction On AxoGen, Inc. (NASDAQ:AXGN) Even After 33% Share Price Boost

We Think AxoGen (NASDAQ:AXGN) Has A Fair Chunk Of Debt

Sep 10
We Think AxoGen (NASDAQ:AXGN) Has A Fair Chunk Of Debt

Market Cool On AxoGen, Inc.'s (NASDAQ:AXGN) Revenues

Aug 09
Market Cool On AxoGen, Inc.'s (NASDAQ:AXGN) Revenues

AxoGen (NASDAQ:AXGN) Has Debt But No Earnings; Should You Worry?

Jan 13
AxoGen (NASDAQ:AXGN) Has Debt But No Earnings; Should You Worry?

Is AxoGen (NASDAQ:AXGN) A Risky Investment?

Sep 10
Is AxoGen (NASDAQ:AXGN) A Risky Investment?

AxoGen: Investors Are Positioned Long Leading Into Q2 FY22 Earnings

Aug 02

CEO

Axogen has no CEO, or we have no data on them.

Leadership Team

NamePositionTenureCompensationOwnership
Nir Naor
Chief Financial Officerless than a yearUS$509.68kno data
Karen Zaderej
Advisorless than a yearUS$5.53m2.6%
$ 14.8m
Erick DeVinney
Chief Innovation Officerless than a yearUS$1.51m0.30%
$ 1.7m
Todd Puckett
Vice President of Operationsless than a yearno datano data
Harold Tamayo
Vice President of Finance & Investor Relationsno datano datano data
Marc Began
Executive VP1.7yrsno datano data
Doris Quackenbush
Vice President of Sales2.8yrsno datano data
Jens Kemp
Chief Marketing Officer1.8yrsno datano data
Ivica Ducic
Chief Medical Officerless than a yearno datano data

0.9yrs

Average Tenure

52.5yo

Average Age

Experienced Management: AXGN's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Paul Thomas
Independent Director4.2yrsUS$220.00k0.049%
$ 276.0k
Guido Neels
Independent Director9.3yrsUS$217.50k0.18%
$ 1.0m
Bruce Mast
Member of Board of Advisorno datano datano data
David Muir
Member of Board of Advisorno datano datano data
John Johnson
Independent Director3.3yrsUS$215.00k0.042%
$ 236.9k
Kathy Weiler
Independent Directorless than a yearUS$293.37kno data
Alan Levine
Independent Director5.5yrsUS$217.50k0.069%
$ 389.1k
Amy Wendell
Independent Lead Director8.2yrsUS$255.00k0.18%
$ 1.0m
William Burke
Independent Director2.3yrsUS$220.00k0.063%
$ 360.0k
Joseph Tyndall
Independent Director1.9yrsUS$205.00k0.051%
$ 291.0k

3.8yrs

Average Tenure

60yo

Average Age

Experienced Board: AXGN's board of directors are considered experienced (3.8 years average tenure).